HNSA fundamentals
An in-depth look to HANSA BIOPHARMA AB operating, investing, and financing activities
HNSA free cash flow for Q4 23 is -172.54 M SEK. For 2023, HNSA free cash flow was -755.94 M SEK and operating cash flow was -755.65 M SEK.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SEK
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM